Skip to main content
. 2011 Jul 21;63(4):341–345. doi: 10.1016/S0377-1237(07)80011-6

Table 5.

Number of patients with moderate degree of squamous metaplasia

Study Group Number. of patients
0 month 3 months 6 months 12 months
Timolol group (n=21) 3 6 8 12 (57%)
Pilocarpine group (n=22) 2 4 6 9 (41%)
Brimonidine group (n=22) 3 3 5 8 (36%)
Latanoprost group (n=23) 1 5 8 11 (48%)